Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes

BACKGROUND: Ovarian carcinomas presenting homologous recombination deficiency (HRD), which is observed in about 50% of cases, are more sensitive to platinum and PARP inhibitor therapies. Although platinum resistant disease has a low chance to be responsive to platinum-based chemotherapy, a set of pa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: da Costa, Alexandre A. B. A., do Canto, Luisa M., Larsen, Simon Jonas, Ribeiro, Adriana Regina Gonçalves, Stecca, Carlos Eduardo, Petersen, Annabeth Høgh, Aagaard, Mads M., de Brot, Louise, Baumbach, Jan, Baiocchi, Glauco, Achatz, Maria Isabel, Rogatto, Silvia Regina
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503431/
https://ncbi.nlm.nih.gov/pubmed/31060523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5622-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires